Market Tracker

02/23 5:15pm ET

Galapagos NV (NASDAQ:GLPG)

111.41
Delayed Data
As of Feb 23
 -3.61 / -3.14%
Today’s Change
67.30
Today|||52-Week Range
121.09
+18.82%
Year-to-Date
New Strong Sell Stocks for February 16th
Feb 16 / Zacks.com - Paid Partner Content
Lilly's Taltz Positive in Phase III Label Expansion Study
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close115.02
Today’s open112.10
Day’s range110.40 - 112.68
Volume135,251
Average volume (3 months)95,869
Market cap$5.7B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+48.70%
Revenue growth (last year)+227.41%
P/E ratioNM
Price/Sales21.24
Price/Book6.44

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.41+2.24%
CTLTCatalent Inc+0.42+0.99%
----
GRFSGrifols SA+0.30+1.34%
Data as of 4:02pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$143.0M
Annual profit (last year)$59.6M
Net profit margin41.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Onno van de Stolpe
Chief Financial Officer
Bart Filius
Corporate headquarters
Mechelen, Brussels Region

Forecasts